According to a recent study, counties in Pennsylvania near cultivated croplands had significantly higher melanoma rates compared to areas not near farmlands.
Bathing frequency not linked to worsening AD symptoms
According to a recent study, whether atopic dermatitis (AD) patients bathe weekly or daily has no impact on their symptoms.
Laser treatment therapy significantly effective for QoL in HS
According to a recent study, CO2 laser treatment significantly improved quality of life in patients with hidradenitis suppurativa (HS).
Atopic eczema linked to higher instances of suicidal thoughts
According to a recent study, adults with atopic eczema are much more likely to experience suicidal thoughts than those without atopic eczema.
Acne, hyperpigmentation linked to decreased self-esteem, anxiety in international students
According to a recent study, international students with acne and hyperpigmentation had decreased self-esteem, higher anxiety, and perceived impairment in academic success.
Mediterranean diet improves psoriasis severity, regardless of weight loss
According to a recent study, adults with mild-to-moderate psoriasis saw significant improvement in their disease severity while adopting a Mediterranean diet for a 16-week period alongside stable topical therapy.
New-onset depression, anxiety linked to HS, regardless of severity
According to a recent study, patients with hidradenitis suppurativa (HS) had an increased risk of anxiety and new-onset depression that was not directly linked to disease severity.
Risk factors for AD recurrence after discontinuing dupilumab
According to a recent study, investigators uncovered key risk factors for disease recurrence in moderate-to-severe atopic dermatitis (AD) patients after dupilumab discontinuation.
Early onset of HS more prevalent in females
According to a recent study, findings from a new study examining pediatric hidradenitis suppurativa (HS) found patients experience a significant delay in diagnosis. Researchers also linked the predominance of HS in female children with earlier age of onset and age at diagnosis.
Lebrikizumab effective in treating head, neck AD
According to a recent study, lebrikizumab, a monoclonal antibody targeting IL-13, is effective in treating head and neck atopic dermatitis (AD) and erythema at 16 weeks of treatment.
HealthMinute.TV 